The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant PD-1 blockade in patients with resectable desmoplastic melanoma (SWOG 1512).
 
Kari Lynn Kendra
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); GlaxoSmithKline (Inst); Idera (Inst); Immunocore (Inst); Isarti Oncology (Inst); Merck (Inst); Novartis (Inst)
 
James Moon
No Relationships to Disclose
 
Zeynep Eroglu
Consulting or Advisory Role - Elsevier; Genentech/Roche; Natera; Novartis; OncoSec; Regeneron; Sun Pharma
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Siwen Hu-Lieskovan
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Genmab; Guidepoint Global; Regeneron; Xencor
 
William Edgar Carson
No Relationships to Disclose
 
David A. Wada
No Relationships to Disclose
 
Jose A Plaza
No Relationships to Disclose
 
Gino Kim In
Honoraria - Array BioPharma/Pfizer; Bristol-Myers Squibb; regeneron
Consulting or Advisory Role - Bristol-Myers Squibb; Castle Biosciences; Novartis; Sanofi
Speakers' Bureau - Merck; Regeneron; Rockpointe CME; Targeted Oncology
Research Funding - Checkmate Pharmaceuticals (Inst); Idera (Inst); Instil Bio (Inst); Regeneron (Inst); Replimune (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Regeneron
 
Alexandra Ikeguchi
No Relationships to Disclose
 
John Robert Hyngstrom
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andrew Scott Brohl
Consulting or Advisory Role - Bayer; Deciphera
Expert Testimony - GlaxoSmithKline (I)
 
Bartosz Chmielowski
Consulting or Advisory Role - Genentech; IDEAYA Biosciences; Iovance Biotherapeutics; Nektar; Novartis; OncoSec; Sanofi
Research Funding - Advenchen Laboratories (Inst); Array BioPharma (Inst); Ascentage Pharma (Inst); Atreca (Inst); Biothera (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Daiichi Sankyo (Inst); IDEAYA Biosciences (Inst); Idera (Inst); Immunocore (Inst); Infinity Pharmaceuticals (Inst); Instil Bio (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Neon Therapeutics (Inst); Novartis (Inst); PACT Pharma (Inst); RAPT Therapeutics (Inst); Replimune (Inst); Rgenix (Inst); Tolero Pharmaceuticals (Inst); Xencor (Inst)
 
Nikhil I. Khushalani
Stock and Other Ownership Interests - Amarin Corporation; Asensus Surgical; Bellicum Pharmaceuticals
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Castle Biosciences; Genzyme; Immunocore; Incyte; Instil Bio; Iovance Biotherapeutics; Jounce Therapeutics; Merck; NCCN/Pfizer; Nektar; Novartis; Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst); Replimune (Inst)
Other Relationship - Bristol-Myers Squibb/Celgene; Nektar; Regeneron
 
Joseph Markowitz
Stock and Other Ownership Interests - Aflac; Amdocs; Consolidated Edison; CVS; Intel
Honoraria - Springer
Consulting or Advisory Role - Newlink Genetics
Research Funding - Idera (Inst); Jackson Laboratory for Genomic Medicine (Inst); Merck (Inst); Microba (Inst); Morphogenesis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on development of Inhibitors for S100B (Inst); Pending patent on flow cytometry analysis system (Inst); Pending patent on the role of nitric oxide in melanoma. (Inst)
Other Relationship - Springer
 
Marcus Monroe
Consulting or Advisory Role - Merck; Regeneron
 
Kenneth F. Grossmann
Employment - Merck
Consulting or Advisory Role - Array BioPharma; Bristo-Meyers Squibb; Natera; Novartis
 
Vernon K. Sondak
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Iovance Biotherapeutics; Merck/Schering Plough; Novartis; Regeneron
Research Funding - Neogene Therapeutics (Inst); Turnstone Bio (Inst)
 
Elad Sharon
No Relationships to Disclose
 
Michael Wu
No Relationships to Disclose
 
Antoni Ribas
Leadership - Arcus Biosciences; Lutris; PACT Pharma
Stock and Other Ownership Interests - 4c Biomed; Advaxis; Appia Bio; Arcus Biosciences; Compugen; CytomX Therapeutics; Highlight Therapeutics; ImaginAb; ImmPACT-Bio; Inspirna; Isoplexis; Kite/Gilead; Lutris; MapKure; Merus; PACT Pharma; Pluto Immunotherapeutics; RAPT Therapeutics; Synthekine; Tango Therapeutics
Honoraria - Amgen; AstraZeneca; Chugai/Roche; Genentech/Roche; Merck Sharp & Dohme; Novartis; Sanofi; Vedanta Biosciences
Consulting or Advisory Role - Amgen; Chugai Pharma; Merck; Novartis; Sanofi
Research Funding - Agilent (Inst); Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Non-viral gene editing to Arsenal Bio